DAPTOMYCINE NORIDEM 350 mg, powder for solution for injection/for infusion 10 bottles of 10 ml
Active ingredients: (2S)-daptomycin
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for solution for injection or infusion10 bottles of 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DAPTOMYCINE NORIDEM 350 mg, poudre pour solution injectable/pour perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- NORIDEM ENTREPRISES LIMITED (CHYPRE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Apr 2021
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61118764CIP75507498CIP133400955074984Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DAPTOMYCINEpoudre | 350 mg · un flacon de poudre | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.